LEADER 01309nam  2200385 a 450 
001 9910700970003321
005 20110912124707.0
035   $a(CKB)5470000002413325
035   $a(OCoLC)751987679
035   $a(EXLCZ)995470000002413325
100   $a20110912d2011      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAuthorized generic drugs$b[electronic resource] $eshort-term effects and long-term impact
210  1$a[Washington, D.C.] :$cFederal Trade Commission,$d[2011]
215   $a1 online resource (270 unnumbered pages) $ccolor illustrations
300   $aTitle from title screen (viewed on Sept. 12, 2011).
300   $a"August 2011."
320   $aIncludes bibliographical references.
517   $aAuthorized generic drugs 
606   $aDrugs$zUnited States$xGeneric substitution
606   $aPharmaceutical industry$zUnited States
606   $aGeneric drugs$xSide effects$zUnited States
615  0$aDrugs$xGeneric substitution.
615  0$aPharmaceutical industry
615  0$aGeneric drugs$xSide effects
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910700970003321
996   $aAuthorized generic drugs$92879603
997   $aUNINA